dc.contributor.author | Davaran, S | |
dc.contributor.author | Rashidi, MR | |
dc.contributor.author | Hashemi, M | |
dc.date.accessioned | 2018-08-26T09:37:18Z | |
dc.date.available | 2018-08-26T09:37:18Z | |
dc.date.issued | 2001 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58087 | |
dc.description.abstract | The purpose of this study is to develop novel colon-specific drug delivery systems with pH-sensitive swelling and drug release properties. Methacrylic-type polymeric prodrugs with different content levels of 5-amino salicylic acid (5-ASA) were synthesized by free radical copolymerization of metacrylic acid (MAA), polyethylene glycol monomethacrylate (PEGMA), and a methacrylic derivative of 5-ASA (methacryloyloxyethyl 5-amino salicylate [MOES]). The copolymers were characterized, and the drug content of the copolymers was determined. The effect of copolymer composition on the swelling behavior and hydrolytic degradation was studied in simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 7.2). The swelling and hydrolytic behavior of the copolymers was dependent on the content of MAA groups and caused a decrease in gel swelling in SGF or an increase in gel swelling in SIF. Drug release studies showed that increasing content of MAA in the copolymer enhances the hydrolysis in SIF but has no effect in SGF. The results suggest that hydrogen-bonded complexes are formed between MAA and PEG pendant groups and that these pH-sensitive systems could be useful for preparation of a controlled-release formulation of 5-ASA. | |
dc.language.iso | English | |
dc.relation.ispartof | AAPS PharmSciTech | |
dc.subject | macrogol derivative | |
dc.subject | mesalazine | |
dc.subject | nonsteroid antiinflammatory agent | |
dc.subject | poly (methacrylic acid co ethyleneglycol monomethoacrylate co methacryloyloxyethyl 5 amino salicylate) | |
dc.subject | poly (methacrylic acid-co-ethyleneglycol monomethoacrylate-co-methacryloyloxyethyl 5-amino salicylate) | |
dc.subject | polymer | |
dc.subject | polymethacrylic acid derivative | |
dc.subject | mesalazine | |
dc.subject | methacrylic acid derivative | |
dc.subject | methacryloyloxyethyl 5 amino salicylate | |
dc.subject | prodrug | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | chemistry | |
dc.subject | colon | |
dc.subject | delayed release formulation | |
dc.subject | hydrogel | |
dc.subject | pH | |
dc.subject | synthesis | |
dc.subject | complex formation | |
dc.subject | concentration (parameters) | |
dc.subject | controlled release formulation | |
dc.subject | controlled study | |
dc.subject | drug degradation | |
dc.subject | drug delivery system | |
dc.subject | drug hydrolysis | |
dc.subject | drug release | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | hydrogen bond | |
dc.subject | intestine fluid | |
dc.subject | mathematical computing | |
dc.subject | polymerization | |
dc.subject | simulation | |
dc.subject | stomach pH | |
dc.subject | tissue specificity | |
dc.subject | Anti-Inflammatory Agents, Non-Steroidal | |
dc.subject | Colon | |
dc.subject | Delayed-Action Preparations | |
dc.subject | Hydrogels | |
dc.subject | Hydrogen-Ion Concentration | |
dc.subject | Mesalamine | |
dc.subject | Polyethylene Glycols | |
dc.subject | Polymers | |
dc.subject | Polymethacrylic Acids | |
dc.title | Synthesis and characterization of methacrylic derivatives of 5-amino salicylic acid with pH-sensitive swelling properties | |
dc.type | Letter | |
dc.citation.volume | 2 | |
dc.citation.issue | 4 | |
dc.citation.spage | 6 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | doi: 10.1007/BF02830569 | |